Gastrectomy Increases Risk of Gallstone Disease in Gastric Cancers
Our focus delves into an array of cancer treatments that shows a connection between gastrectomy and increased risk for gallstone disease in cases of gastric cancers.
FDA Issues Partial Clinical Hold on Lorigerlimab Trial in Gynecologic Cancers
In a significant move, the FDA has placed a hold on the Lorigerlimab trial due to occurrences of serious safety events.
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma
The section outlines pointers for managing toxicities associated with immune-checkpoint inhibitors in melanoma patients.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma
Highlighting a stepping stone in glioma treatment, the FDA has granted fast track designation to SRN-101, a promising therapy for recurrent high-grade glioma.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma
A breakthrough has been noted in multiple myeloma treatment, where a novel small molecule has displayed early activity against pretreated variants of the disease.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC
The final discussion revolves around a comparison of the quality of life outcomes when treated with protons and photons in OPSCC.
